Age-related Macular Degeneration Market - Global Outlook and Forecast 2022-2028

January 2022 | 67 pages | ID: A2BBA5DF4299EN
Market Monitor Global

Abstracts

This report contains market size and forecasts of Age-related Macular Degeneration in Global, including the following market information:

Global Age-related Macular Degeneration Market Revenue, 2017-2022, 2023-2028, ($ millions)

Global top five companies in 2021 (%)

The global Age-related Macular Degeneration market was valued at 15780 million in 2021 and is projected to reach US$ 22240 million by 2028, at a CAGR of 5.0% during the forecast period.

The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.

Wet AMD Segment to Reach $ Million by 2028, with a % CAGR in next six years.

The global key manufacturers of Age-related Macular Degeneration include Bayer HealthCare, F. Hoffmann-La Roche, Novartis, Regeneron Pharmaceuticals, Alcon, Allergan, Avalanche, Bausch+Lomb and Gilead Sciences, etc. In 2021, the global top five players have a share approximately % in terms of revenue.

MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Age-related Macular Degeneration companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.

Total Market by Segment:

Global Age-related Macular Degeneration Market, by Type, 2017-2022, 2023-2028 ($ millions)

Global Age-related Macular Degeneration Market Segment Percentages, by Type, 2021 (%)

• Wet AMD
• Dry AMD

Global Age-related Macular Degeneration Market, by Application, 2017-2022, 2023-2028 ($ millions)

Global Age-related Macular Degeneration Market Segment Percentages, by Application, 2021 (%)

• Drugstore
• Hospital
• Others

Global Age-related Macular Degeneration Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions)

Global Age-related Macular Degeneration Market Segment Percentages, By Region and Country, 2021 (%)

• North America
• US
• Canada
• Mexico
• Europe
• Germany
• France
• U.K.
• Italy
• Russia
• Nordic Countries
• Benelux
• Rest of Europe
• Asia
• China
• Japan
• South Korea
• Southeast Asia
• India
• Rest of Asia
• South America
• Brazil
• Argentina
• Rest of South America
• Middle East & Africa
• Turkey
• Israel
• Saudi Arabia
• UAE
• Rest of Middle East & Africa

Competitor Analysis

The report also provides analysis of leading market participants including:

Key companies Age-related Macular Degeneration revenues in global market, 2017-2022 (estimated), ($ millions)

Key companies Age-related Macular Degeneration revenues share in global market, 2021 (%)

Further, the report presents profiles of competitors in the market, key players include:

• Bayer HealthCare
• F. Hoffmann-La Roche
• Novartis
• Regeneron Pharmaceuticals
• Alcon
• Allergan
• Avalanche
• Bausch+Lomb
• Gilead Sciences
• Iconic Therapeutics
• Neurotech Pharmaceuticals
• Ohr Pharmaceutical

Contents

1 INTRODUCTION TO RESEARCH & ANALYSIS REPORTS

1.1 Age-related Macular Degeneration Market Definition
1.2 Market Segments
  1.2.1 Market by Type
  1.2.2 Market by Application
1.3 Global Age-related Macular Degeneration Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
  1.5.1 Research Methodology
  1.5.2 Research Process
  1.5.3 Base Year
  1.5.4 Report Assumptions & Caveats

2 GLOBAL AGE-RELATED MACULAR DEGENERATION OVERALL MARKET SIZE

2.1 Global Age-related Macular Degeneration Market Size: 2021 VS 2028
2.2 Global Age-related Macular Degeneration Market Size, Prospects & Forecasts: 2017-2028
2.3 Key Market Trends, Opportunity, Drivers and Restraints
  2.3.1 Market Opportunities & Trends
  2.3.2 Market Drivers
  2.3.3 Market Restraints

3 COMPANY LANDSCAPE

3.1 Top Age-related Macular Degeneration Players in Global Market
3.2 Top Global Age-related Macular Degeneration Companies Ranked by Revenue
3.3 Global Age-related Macular Degeneration Revenue by Companies
3.4 Top 3 and Top 5 Age-related Macular Degeneration Companies in Global Market, by Revenue in 2021
3.5 Global Companies Age-related Macular Degeneration Product Type
3.6 Tier 1, Tier 2 and Tier 3 Age-related Macular Degeneration Players in Global Market
  3.6.1 List of Global Tier 1 Age-related Macular Degeneration Companies
  3.6.2 List of Global Tier 2 and Tier 3 Age-related Macular Degeneration Companies

4 MARKET SIGHTS BY PRODUCT

4.1 Overview
  4.1.1 by Type - Global Age-related Macular Degeneration Market Size Markets, 2021 & 2028
  4.1.2 Wet AMD
  4.1.3 Dry AMD
4.2 By Type - Global Age-related Macular Degeneration Revenue & Forecasts
  4.2.1 By Type - Global Age-related Macular Degeneration Revenue, 2017-2022
  4.2.2 By Type - Global Age-related Macular Degeneration Revenue, 2023-2028
  4.2.3 By Type - Global Age-related Macular Degeneration Revenue Market Share, 2017-2028

5 SIGHTS BY APPLICATION

5.1 Overview
  5.1.1 By Application - Global Age-related Macular Degeneration Market Size, 2021 & 2028
  5.1.2 Drugstore
  5.1.3 Hospital
  5.1.4 Others
5.2 By Application - Global Age-related Macular Degeneration Revenue & Forecasts
  5.2.1 By Application - Global Age-related Macular Degeneration Revenue, 2017-2022
  5.2.2 By Application - Global Age-related Macular Degeneration Revenue, 2023-2028
  5.2.3 By Application - Global Age-related Macular Degeneration Revenue Market Share, 2017-2028

6 SIGHTS BY REGION

6.1 By Region - Global Age-related Macular Degeneration Market Size, 2021 & 2028
6.2 By Region - Global Age-related Macular Degeneration Revenue & Forecasts
  6.2.1 By Region - Global Age-related Macular Degeneration Revenue, 2017-2022
  6.2.2 By Region - Global Age-related Macular Degeneration Revenue, 2023-2028
  6.2.3 By Region - Global Age-related Macular Degeneration Revenue Market Share, 2017-2028
6.3 North America
  6.3.1 By Country - North America Age-related Macular Degeneration Revenue, 2017-2028
  6.3.2 US Age-related Macular Degeneration Market Size, 2017-2028
  6.3.3 Canada Age-related Macular Degeneration Market Size, 2017-2028
  6.3.4 Mexico Age-related Macular Degeneration Market Size, 2017-2028
6.4 Europe
  6.4.1 By Country - Europe Age-related Macular Degeneration Revenue, 2017-2028
  6.4.2 Germany Age-related Macular Degeneration Market Size, 2017-2028
  6.4.3 France Age-related Macular Degeneration Market Size, 2017-2028
  6.4.4 U.K. Age-related Macular Degeneration Market Size, 2017-2028
  6.4.5 Italy Age-related Macular Degeneration Market Size, 2017-2028
  6.4.6 Russia Age-related Macular Degeneration Market Size, 2017-2028
  6.4.7 Nordic Countries Age-related Macular Degeneration Market Size, 2017-2028
  6.4.8 Benelux Age-related Macular Degeneration Market Size, 2017-2028
6.5 Asia
  6.5.1 By Region - Asia Age-related Macular Degeneration Revenue, 2017-2028
  6.5.2 China Age-related Macular Degeneration Market Size, 2017-2028
  6.5.3 Japan Age-related Macular Degeneration Market Size, 2017-2028
  6.5.4 South Korea Age-related Macular Degeneration Market Size, 2017-2028
  6.5.5 Southeast Asia Age-related Macular Degeneration Market Size, 2017-2028
  6.5.6 India Age-related Macular Degeneration Market Size, 2017-2028
6.6 South America
  6.6.1 By Country - South America Age-related Macular Degeneration Revenue, 2017-2028
  6.6.2 Brazil Age-related Macular Degeneration Market Size, 2017-2028
  6.6.3 Argentina Age-related Macular Degeneration Market Size, 2017-2028
6.7 Middle East & Africa
  6.7.1 By Country - Middle East & Africa Age-related Macular Degeneration Revenue, 2017-2028
  6.7.2 Turkey Age-related Macular Degeneration Market Size, 2017-2028
  6.7.3 Israel Age-related Macular Degeneration Market Size, 2017-2028
  6.7.4 Saudi Arabia Age-related Macular Degeneration Market Size, 2017-2028
  6.7.5 UAE Age-related Macular Degeneration Market Size, 2017-2028

7 PLAYERS PROFILES

7.1 Bayer HealthCare
  7.1.1 Bayer HealthCare Corporate Summary
  7.1.2 Bayer HealthCare Business Overview
  7.1.3 Bayer HealthCare Age-related Macular Degeneration Major Product Offerings
  7.1.4 Bayer HealthCare Age-related Macular Degeneration Revenue in Global Market (2017-2022)
  7.1.5 Bayer HealthCare Key News
7.2 F. Hoffmann-La Roche
  7.2.1 F. Hoffmann-La Roche Corporate Summary
  7.2.2 F. Hoffmann-La Roche Business Overview
  7.2.3 F. Hoffmann-La Roche Age-related Macular Degeneration Major Product Offerings
  7.2.4 F. Hoffmann-La Roche Age-related Macular Degeneration Revenue in Global Market (2017-2022)
  7.2.5 F. Hoffmann-La Roche Key News
7.3 Novartis
  7.3.1 Novartis Corporate Summary
  7.3.2 Novartis Business Overview
  7.3.3 Novartis Age-related Macular Degeneration Major Product Offerings
  7.3.4 Novartis Age-related Macular Degeneration Revenue in Global Market (2017-2022)
  7.3.5 Novartis Key News
7.4 Regeneron Pharmaceuticals
  7.4.1 Regeneron Pharmaceuticals Corporate Summary
  7.4.2 Regeneron Pharmaceuticals Business Overview
  7.4.3 Regeneron Pharmaceuticals Age-related Macular Degeneration Major Product Offerings
  7.4.4 Regeneron Pharmaceuticals Age-related Macular Degeneration Revenue in Global Market (2017-2022)
  7.4.5 Regeneron Pharmaceuticals Key News
7.5 Alcon
  7.5.1 Alcon Corporate Summary
  7.5.2 Alcon Business Overview
  7.5.3 Alcon Age-related Macular Degeneration Major Product Offerings
  7.5.4 Alcon Age-related Macular Degeneration Revenue in Global Market (2017-2022)
  7.5.5 Alcon Key News
7.6 Allergan
  7.6.1 Allergan Corporate Summary
  7.6.2 Allergan Business Overview
  7.6.3 Allergan Age-related Macular Degeneration Major Product Offerings
  7.6.4 Allergan Age-related Macular Degeneration Revenue in Global Market (2017-2022)
  7.6.5 Allergan Key News
7.7 Avalanche
  7.7.1 Avalanche Corporate Summary
  7.7.2 Avalanche Business Overview
  7.7.3 Avalanche Age-related Macular Degeneration Major Product Offerings
  7.7.4 Avalanche Age-related Macular Degeneration Revenue in Global Market (2017-2022)
  7.7.5 Avalanche Key News
7.8 Bausch+Lomb
  7.8.1 Bausch+Lomb Corporate Summary
  7.8.2 Bausch+Lomb Business Overview
  7.8.3 Bausch+Lomb Age-related Macular Degeneration Major Product Offerings
  7.8.4 Bausch+Lomb Age-related Macular Degeneration Revenue in Global Market (2017-2022)
  7.8.5 Bausch+Lomb Key News
7.9 Gilead Sciences
  7.9.1 Gilead Sciences Corporate Summary
  7.9.2 Gilead Sciences Business Overview
  7.9.3 Gilead Sciences Age-related Macular Degeneration Major Product Offerings
  7.9.4 Gilead Sciences Age-related Macular Degeneration Revenue in Global Market (2017-2022)
  7.9.5 Gilead Sciences Key News
7.10 Iconic Therapeutics
  7.10.1 Iconic Therapeutics Corporate Summary
  7.10.2 Iconic Therapeutics Business Overview
  7.10.3 Iconic Therapeutics Age-related Macular Degeneration Major Product Offerings
  7.10.4 Iconic Therapeutics Age-related Macular Degeneration Revenue in Global Market (2017-2022)
  7.10.5 Iconic Therapeutics Key News
7.11 Neurotech Pharmaceuticals
  7.11.1 Neurotech Pharmaceuticals Corporate Summary
  7.11.2 Neurotech Pharmaceuticals Business Overview
  7.11.3 Neurotech Pharmaceuticals Age-related Macular Degeneration Major Product Offerings
  7.11.4 Neurotech Pharmaceuticals Age-related Macular Degeneration Revenue in Global Market (2017-2022)
  7.11.5 Neurotech Pharmaceuticals Key News
7.12 Ohr Pharmaceutical
  7.12.1 Ohr Pharmaceutical Corporate Summary
  7.12.2 Ohr Pharmaceutical Business Overview
  7.12.3 Ohr Pharmaceutical Age-related Macular Degeneration Major Product Offerings
  7.12.4 Ohr Pharmaceutical Age-related Macular Degeneration Revenue in Global Market (2017-2022)
  7.12.5 Ohr Pharmaceutical Key News

8 CONCLUSION

9 APPENDIX

9.1 Note
9.2 Examples of Clients
9.3 Disclaimer

List Of Tables

LIST OF TABLES

Table 1. Age-related Macular Degeneration Market Opportunities & Trends in Global Market
Table 2. Age-related Macular Degeneration Market Drivers in Global Market
Table 3. Age-related Macular Degeneration Market Restraints in Global Market
Table 4. Key Players of Age-related Macular Degeneration in Global Market
Table 5. Top Age-related Macular Degeneration Players in Global Market, Ranking by Revenue (2021)
Table 6. Global Age-related Macular Degeneration Revenue by Companies, (US$, Mn), 2017-2022
Table 7. Global Age-related Macular Degeneration Revenue Share by Companies, 2017-2022
Table 8. Global Companies Age-related Macular Degeneration Product Type
Table 9. List of Global Tier 1 Age-related Macular Degeneration Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Age-related Macular Degeneration Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 11. By Type – Global Age-related Macular Degeneration Revenue, (US$, Mn), 2021 & 2028
Table 12. By Type - Age-related Macular Degeneration Revenue in Global (US$, Mn), 2017-2022
Table 13. By Type - Age-related Macular Degeneration Revenue in Global (US$, Mn), 2023-2028
Table 14. By Application – Global Age-related Macular Degeneration Revenue, (US$, Mn), 2021 & 2028
Table 15. By Application - Age-related Macular Degeneration Revenue in Global (US$, Mn), 2017-2022
Table 16. By Application - Age-related Macular Degeneration Revenue in Global (US$, Mn), 2023-2028
Table 17. By Region – Global Age-related Macular Degeneration Revenue, (US$, Mn), 2021 & 2028
Table 18. By Region - Global Age-related Macular Degeneration Revenue (US$, Mn), 2017-2022
Table 19. By Region - Global Age-related Macular Degeneration Revenue (US$, Mn), 2023-2028
Table 20. By Country - North America Age-related Macular Degeneration Revenue, (US$, Mn), 2017-2022
Table 21. By Country - North America Age-related Macular Degeneration Revenue, (US$, Mn), 2023-2028
Table 22. By Country - Europe Age-related Macular Degeneration Revenue, (US$, Mn), 2017-2022
Table 23. By Country - Europe Age-related Macular Degeneration Revenue, (US$, Mn), 2023-2028
Table 24. By Region - Asia Age-related Macular Degeneration Revenue, (US$, Mn), 2017-2022
Table 25. By Region - Asia Age-related Macular Degeneration Revenue, (US$, Mn), 2023-2028
Table 26. By Country - South America Age-related Macular Degeneration Revenue, (US$, Mn), 2017-2022
Table 27. By Country - South America Age-related Macular Degeneration Revenue, (US$, Mn), 2023-2028
Table 28. By Country - Middle East & Africa Age-related Macular Degeneration Revenue, (US$, Mn), 2017-2022
Table 29. By Country - Middle East & Africa Age-related Macular Degeneration Revenue, (US$, Mn), 2023-2028
Table 30. Bayer HealthCare Corporate Summary
Table 31. Bayer HealthCare Age-related Macular Degeneration Product Offerings
Table 32. Bayer HealthCare Age-related Macular Degeneration Revenue (US$, Mn), (2017-2022)
Table 33. F. Hoffmann-La Roche Corporate Summary
Table 34. F. Hoffmann-La Roche Age-related Macular Degeneration Product Offerings
Table 35. F. Hoffmann-La Roche Age-related Macular Degeneration Revenue (US$, Mn), (2017-2022)
Table 36. Novartis Corporate Summary
Table 37. Novartis Age-related Macular Degeneration Product Offerings
Table 38. Novartis Age-related Macular Degeneration Revenue (US$, Mn), (2017-2022)
Table 39. Regeneron Pharmaceuticals Corporate Summary
Table 40. Regeneron Pharmaceuticals Age-related Macular Degeneration Product Offerings
Table 41. Regeneron Pharmaceuticals Age-related Macular Degeneration Revenue (US$, Mn), (2017-2022)
Table 42. Alcon Corporate Summary
Table 43. Alcon Age-related Macular Degeneration Product Offerings
Table 44. Alcon Age-related Macular Degeneration Revenue (US$, Mn), (2017-2022)
Table 45. Allergan Corporate Summary
Table 46. Allergan Age-related Macular Degeneration Product Offerings
Table 47. Allergan Age-related Macular Degeneration Revenue (US$, Mn), (2017-2022)
Table 48. Avalanche Corporate Summary
Table 49. Avalanche Age-related Macular Degeneration Product Offerings
Table 50. Avalanche Age-related Macular Degeneration Revenue (US$, Mn), (2017-2022)
Table 51. Bausch+Lomb Corporate Summary
Table 52. Bausch+Lomb Age-related Macular Degeneration Product Offerings
Table 53. Bausch+Lomb Age-related Macular Degeneration Revenue (US$, Mn), (2017-2022)
Table 54. Gilead Sciences Corporate Summary
Table 55. Gilead Sciences Age-related Macular Degeneration Product Offerings
Table 56. Gilead Sciences Age-related Macular Degeneration Revenue (US$, Mn), (2017-2022)
Table 57. Iconic Therapeutics Corporate Summary
Table 58. Iconic Therapeutics Age-related Macular Degeneration Product Offerings
Table 59. Iconic Therapeutics Age-related Macular Degeneration Revenue (US$, Mn), (2017-2022)
Table 60. Neurotech Pharmaceuticals Corporate Summary
Table 61. Neurotech Pharmaceuticals Age-related Macular Degeneration Product Offerings
Table 62. Neurotech Pharmaceuticals Age-related Macular Degeneration Revenue (US$, Mn), (2017-2022)
Table 63. Ohr Pharmaceutical Corporate Summary
Table 64. Ohr Pharmaceutical Age-related Macular Degeneration Product Offerings
Table 65. Ohr Pharmaceutical Age-related Macular Degeneration Revenue (US$, Mn), (2017-2022)

List Of Figures

LIST OF FIGURES

Figure 1. Age-related Macular Degeneration Segment by Type in 2021
Figure 2. Age-related Macular Degeneration Segment by Application in 2021
Figure 3. Global Age-related Macular Degeneration Market Overview: 2020
Figure 4. Key Caveats
Figure 5. Global Age-related Macular Degeneration Market Size: 2021 VS 2028 (US$, Mn)
Figure 6. Global Age-related Macular Degeneration Revenue, 2017-2028 (US$, Mn)
Figure 7. The Top 3 and 5 Players Market Share by Age-related Macular Degeneration Revenue in 2021
Figure 8. By Type - Global Age-related Macular Degeneration Revenue Market Share, 2017-2028
Figure 9. By Application - Global Age-related Macular Degeneration Revenue Market Share, 2017-2028
Figure 10. By Region - Global Age-related Macular Degeneration Revenue Market Share, 2017-2028
Figure 11. By Country - North America Age-related Macular Degeneration Revenue Market Share, 2017-2028
Figure 12. US Age-related Macular Degeneration Revenue, (US$, Mn), 2017-2028
Figure 13. Canada Age-related Macular Degeneration Revenue, (US$, Mn), 2017-2028
Figure 14. Mexico Age-related Macular Degeneration Revenue, (US$, Mn), 2017-2028
Figure 15. By Country - Europe Age-related Macular Degeneration Revenue Market Share, 2017-2028
Figure 16. Germany Age-related Macular Degeneration Revenue, (US$, Mn), 2017-2028
Figure 17. France Age-related Macular Degeneration Revenue, (US$, Mn), 2017-2028
Figure 18. U.K. Age-related Macular Degeneration Revenue, (US$, Mn), 2017-2028
Figure 19. Italy Age-related Macular Degeneration Revenue, (US$, Mn), 2017-2028
Figure 20. Russia Age-related Macular Degeneration Revenue, (US$, Mn), 2017-2028
Figure 21. Nordic Countries Age-related Macular Degeneration Revenue, (US$, Mn), 2017-2028
Figure 22. Benelux Age-related Macular Degeneration Revenue, (US$, Mn), 2017-2028
Figure 23. By Region - Asia Age-related Macular Degeneration Revenue Market Share, 2017-2028
Figure 24. China Age-related Macular Degeneration Revenue, (US$, Mn), 2017-2028
Figure 25. Japan Age-related Macular Degeneration Revenue, (US$, Mn), 2017-2028
Figure 26. South Korea Age-related Macular Degeneration Revenue, (US$, Mn), 2017-2028
Figure 27. Southeast Asia Age-related Macular Degeneration Revenue, (US$, Mn), 2017-2028
Figure 28. India Age-related Macular Degeneration Revenue, (US$, Mn), 2017-2028
Figure 29. By Country - South America Age-related Macular Degeneration Revenue Market Share, 2017-2028
Figure 30. Brazil Age-related Macular Degeneration Revenue, (US$, Mn), 2017-2028
Figure 31. Argentina Age-related Macular Degeneration Revenue, (US$, Mn), 2017-2028
Figure 32. By Country - Middle East & Africa Age-related Macular Degeneration Revenue Market Share, 2017-2028
Figure 33. Turkey Age-related Macular Degeneration Revenue, (US$, Mn), 2017-2028
Figure 34. Israel Age-related Macular Degeneration Revenue, (US$, Mn), 2017-2028
Figure 35. Saudi Arabia Age-related Macular Degeneration Revenue, (US$, Mn), 2017-2028
Figure 36. UAE Age-related Macular Degeneration Revenue, (US$, Mn), 2017-2028
Figure 37. Bayer HealthCare Age-related Macular Degeneration Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 38. F. Hoffmann-La Roche Age-related Macular Degeneration Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 39. Novartis Age-related Macular Degeneration Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 40. Regeneron Pharmaceuticals Age-related Macular Degeneration Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 41. Alcon Age-related Macular Degeneration Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 42. Allergan Age-related Macular Degeneration Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 43. Avalanche Age-related Macular Degeneration Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 44. Bausch+Lomb Age-related Macular Degeneration Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 45. Gilead Sciences Age-related Macular Degeneration Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 46. Iconic Therapeutics Age-related Macular Degeneration Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 47. Neurotech Pharmaceuticals Age-related Macular Degeneration Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 48. Ohr Pharmaceutical Age-related Macular Degeneration Revenue Year Over Year Growth (US$, Mn) & (2017-2022)